GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
1–10 of 228 posts
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#2Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#3"The partners plan to use 23andMe’s data to jointly discover drug targets."
They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#4Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#5Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#6Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#7Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Or hacked.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#8Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#9I'm sure you know how an ex-cop turned out to be the infamous golden state killer.
While it's wonderful that these cold cases are now being solved, it also raises a strong privacy issue and also moral one.
If criminals know they will be caught eventually thanks to genealogy and DNA cataloging, wouldn't this drive them to get rid of the DNA altogether and escalate their crime?
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#10Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.